The majority of advances in cancer therapy have been achieved based on developments in
public awareness, as well as novel diagnostic and therapeutic modalities. Treatment …

Polymersomes have been extensively investigated for drug delivery as nanocarriers for two
decades due to a series of advantages including high stability under physiological …

A variety of bioactive materials are currently developed to expand T cells ex vivo for adoptive
T cell immunotherapy, also known as called artificial antigen-presenting cells (aAPCs) …

The term nanocarrier refers to sub-micrometric particles of less than 100 nm, designed to
transport, distribute, and release nanotechnology-based drug delivery systems. siRNA …

Polymersomes are vesicular structures self‐assembled from amphiphilic block copolymers
and are considered an alternative to liposomes for applications in drug delivery …

Regulating innate immunity is an emerging approach to improve cancer immunotherapy.
Such regulation requires engaging myeloid cells by delivering immunomodulatory …

The application of amphiphilic block copolymer for drug delivery has received immense
attention in recent years. Polymersomes are favorable types of polymeric systems that can …

A significant factor hindering the clinical translation of polymersomes as vesicular
nanocarriers is the limited availability of comparative studies detailing their interaction with …

Nano-and micrometer-sized compartments composed of synthetic polymers are designed to
mimic spatial and temporal divisions found in nature. Self-assembly of polymers into …

The antitumor immunity can be enhanced through the synchronized codelivery of antigens
and immunostimulatory adjuvants to antigen-presenting cells, particularly dendritic cells …